Dr. Roberto Bonasio's lab at the University of Pennsylvania studies how memories can be encoded in organisms beyond the nervous system, using planarians, a type of flatworm capable of regenerating their brains. The lab investigates the molecular mechanisms behind memory retention and transmission through both neural and non-neural pathways. Their work aims to enhance our understanding of memory formation and inheritance, with potential insights applicable to more complex brains, including human brains.

Dr. Jorge Ivan Alvarez's lab at the University of Pennsylvania focuses on understanding how mitochondria affect the blood-brain barrier (BBB) and their connection to neuropsychiatric disorders. They investigate how deficiencies in mitochondrial function can compromise BBB integrity, which may lead to conditions like schizophrenia and other neurodevelopmental disorders. The lab combines insights from neuroimmunology and developmental biology to explore new therapeutic approaches for these conditions.

Dr. Dustin Brisson's lab at the University of Pennsylvania studies how seasonal patterns of black-legged ticks affect the transmission of diseases in humans. By researching the life cycles of these ticks and the pathogens they carry, the lab aims to uncover how changes in the environment influence disease spread. This work is crucial for improving public health management of tick-borne illnesses in North America.

Dr. Shefali Setia Verma’s lab focuses on improving the early detection and management of endometriosis, a condition affecting millions of women. The team aims to develop innovative predictive models that integrate genetic and environmental factors to identify women at risk. By creating tools for early diagnosis, the lab hopes to enhance treatment options and improve long-term health outcomes for women with endometriosis and its related health issues.

Dr. Li-San Wang's lab at the University of Pennsylvania is focused on understanding Alzheimer's Disease (AD), particularly in Asian American populations that have been historically underrepresented in genetic research. The lab is conducting the Asian Cohort for Alzheimer's Disease (ACAD) study, which aims to recruit over 5,000 participants of Chinese, Korean, and Vietnamese descent to explore genetic factors affecting AD risk and to develop targeted screening methods. Through this research, the lab hopes to improve the diagnosis and treatment of Alzheimer's Disease for these communities.

Dr. Peijing Jeremy Wang's lab at the University of Pennsylvania focuses on understanding meiosis, the process that reduces the chromosome number in cells to produce gametes. The lab investigates how certain proteins and factors influence this process and contribute to genetic diversity and overall reproductive health. By tackling the molecular mechanisms behind meiosis, the research aims to shed light on issues related to infertility and birth defects.

Dr. Xiaowei Xu's lab focuses on developing innovative therapies using advanced immunological approaches to combat melanoma, a serious skin cancer. The lab utilizes humanized mouse models to study immune responses and explore the potential of engineered immune cells and extracellular vesicles in targeted cancer therapies. Their research aims to make significant advancements in the effectiveness of existing cancer treatments while minimizing side effects.

Dr. Hong Xu's lab at the University of Pennsylvania focuses on understanding tauopathies, which are neurodegenerative diseases associated with the abnormal accumulation of tau proteins in the brain. The lab investigates how a protein called ASAP1 influences the spreading of tau pathology, potentially leading to better treatments for conditions like Alzheimer's disease. By studying how tau spreads and its interaction with cellular pathways, the lab aims to identify new therapeutic targets for these devastating diseases.

Dr. Xiaolu Yang's lab at the University of Pennsylvania focuses on understanding how specific proteins affect the development and progression of neurodegenerative diseases like ALS and FTD. They investigate the roles of unique proteins involved in maintaining the stability and function of other proteins in the cell, particularly regarding protein aggregation, which is a key feature in many diseases. Their research aims to explore potential therapeutic strategies to combat these conditions by enhancing our understanding of protein quality control mechanisms in cells.